Login

Ben McMillan, founder and CIO of IDX Digital Assets, discusses the key factors driving the crypto market in an interview with CNBC Crypto World. 00:10:00

Share On Facebook Share On Twitter

Ben McMillan, CIO of IDX Digital Assets,

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Assessing Austria's IT Industry in Global Competition | Helmut Fallmann , CEO of Fabasoft AG
00:10:00
Interview with Willem Middelkoop on Discovery Investing in Mining
00:10:00
Business is not always a easy way to make money|Bruce Hamilton,General Partner, Everybody Ventures
00:10:00
Impact of JobKeeper and JobSeeker on Customers, Government's Role in Energy Sector, and Investment Uncertainty | Frank Calabria, CEO, Origin Energy Ltd .
00:10:00
Kleiner Perkins was founded in the 1970s by Tom Perkins and Eugene Kleiner|Mamoon Hamid,Partner,Kleiner Perkins
00:10:00
Abel Travis, VP & Head of Fundamental Underwriters at AF Group, emphasizes that innovation cannot thrive in isolation..|Amund Tøftum is CEO in AF Gruppen
00:10:00
Heikki Linnanen, CIO of Caverion, reflects on a decade of Business Technology Standard in anniversary interviews.
00:10:00
Jennifer Chow discusses promising results of cltx C therapy, signaling future trials and regulatory milestones in cancer treatment | Jennifer Chow, CEO,Chimeric Therapeutics Ltd.
00:10:00
Exploring the Rise of IPEOs: Private Equity's Dominance in Tech Innovation Acquisition and What Lies Ahead|Bill Wise, CEO, Mediaocean
00:10:00
A company's financial performance speaks the volumes|Clara Brenner,General Partner, Urban Innovation Fund
00:10:00
Edtech pre-seed investment fund seeking founders with long-term mindsets|Justin Su,Founder,Long Term Impact
00:10:00
Cambridge College Showcases Underground Charging Tech and Rugged Rover at Noms Pavilion

© 2026 Nehu